Eisai's Attacks Pressure Feds To Patch Exclusivity Holes
Eisai Co. Ltd.'s unusual two-pronged attack on federal agencies over regulatory delays that have prevented it from selling two new prescription drugs could help decide whether drugmakers whose products pose risks...To view the full article, register now.
Already a subscriber? Click here to view full article